Daymark Wealth Partners LLC Lowers Holdings in Aflac Incorporated (NYSE:AFL)

Daymark Wealth Partners LLC reduced its position in Aflac Incorporated (NYSE:AFL) by 1.1% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 21,162 shares of the financial services provider’s stock after selling 234 shares during the quarter. Daymark Wealth Partners LLC’s holdings in Aflac were worth $2,353,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of AFL. Private Trust Co. NA increased its stake in shares of Aflac by 1.3% during the fourth quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock worth $791,000 after acquiring an additional 99 shares during the period. Optas LLC boosted its holdings in Aflac by 3.5% in the 1st quarter. Optas LLC now owns 2,949 shares of the financial services provider’s stock valued at $328,000 after purchasing an additional 101 shares in the last quarter. Family Legacy Inc. boosted its holdings in Aflac by 4.3% in the 4th quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider’s stock valued at $270,000 after purchasing an additional 107 shares in the last quarter. Ashton Thomas Private Wealth LLC increased its position in Aflac by 1.9% during the 4th quarter. Ashton Thomas Private Wealth LLC now owns 5,927 shares of the financial services provider’s stock worth $613,000 after purchasing an additional 110 shares during the period. Finally, Titleist Asset Management LLC increased its position in Aflac by 3.4% during the 4th quarter. Titleist Asset Management LLC now owns 3,324 shares of the financial services provider’s stock worth $344,000 after purchasing an additional 110 shares during the period. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Performance

NYSE AFL opened at $102.51 on Thursday. The company has a quick ratio of 0.09, a current ratio of 0.09 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a fifty-two week low of $88.00 and a fifty-two week high of $115.50. The business has a fifty day moving average of $104.67 and a 200-day moving average of $105.20. The stock has a market cap of $55.42 billion, a price-to-earnings ratio of 16.02, a price-to-earnings-growth ratio of 3.22 and a beta of 0.82.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing the consensus estimate of $1.67 by ($0.01). The firm had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. The company’s revenue for the quarter was down 37.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.66 EPS. As a group, analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were paid a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.26%. The ex-dividend date was Wednesday, May 21st. Aflac’s dividend payout ratio is presently 36.25%.

Analysts Set New Price Targets

AFL has been the subject of several recent analyst reports. Keefe, Bruyette & Woods raised their price target on Aflac from $104.00 to $106.00 and gave the company a “market perform” rating in a report on Wednesday, May 7th. Piper Sandler raised their price objective on shares of Aflac from $118.00 to $124.00 and gave the company an “overweight” rating in a research note on Wednesday, April 2nd. Wall Street Zen cut shares of Aflac from a “hold” rating to a “sell” rating in a report on Monday, May 5th. Raymond James Financial reduced their price target on shares of Aflac from $115.00 to $110.00 and set an “outperform” rating for the company in a research report on Thursday, May 29th. Finally, Morgan Stanley upped their price target on Aflac from $100.00 to $105.00 and gave the stock an “equal weight” rating in a report on Monday, May 19th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $104.93.

Insider Transactions at Aflac

In related news, Director Masatoshi Koide sold 37,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the sale, the director now directly owns 70,992 shares in the company, valued at approximately $7,496,045.28. The trade was a 34.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Arthur Reginald Collins sold 2,750 shares of the company’s stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the transaction, the director now directly owns 6,728 shares of the company’s stock, valued at $711,149.60. This trade represents a 29.01% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 40,750 shares of company stock worth $4,304,295 over the last quarter. 0.90% of the stock is currently owned by insiders.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.